Corporate venture capital may be what fills in the large gaps VC has left behind, with CVC deals about 60 percent larger than VC deals on the whole. Healthcare corporate venture capital deals are up nearly 40 percent compared to Q1 and funding is up 34 percent, according to a report from CB Insights. There were […]
Mayo recently acquired a minority equity stake in Centerphase Solutions Inc., which is developing ways to speed drug industry-sponsored clinical trials run by major academic research institutions like Mayo. Founded in late 2009 by veterans of Merck Capital Ventures, Centerphase has already raised $2.6 million from investors.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.